US stocks starting with I
The official accounts of 106 companies listed in the United States whose name starts with I: revenue and net profit for the latest fiscal year, as stated in the annual report (Form 10-K) each one files with the SEC, in US dollars. Each one links to its page, with the document every figure comes from.
| Company | Ticker | Fiscal year | Revenue | Net profit |
|---|---|---|---|---|
| i3 Verticals | NASDAQ: IIIV | 2025 | $213.2m | $17.9m |
| IA | NASDAQ: IA | 2025 | $84.3m | $15.6m |
| IBEX | NASDAQ: IBEX | 2026 | $644.1m | $46.3m |
| IBM | NYSE: IBM | 2025 | $67,535m | $10,593m |
| Ibotta | NYSE: IBTA | 2025 | $342.4m | $3.6m |
| Icahn Enterprises | NASDAQ: IEP | 2025 | $9,658m | −$299.0m |
| ICF International | NASDAQ: ICFI | 2025 | $1,873m | $91.6m |
| Ichor | NASDAQ: ICHR | 2025 | $947.7m | −$52.8m |
| ICU Medical | NASDAQ: ICUI | 2025 | $2,231m | $0.7m |
| Idacorp | NYSE: IDA | 2025 | $1,813m | $323.5m |
| Idaho Strategic Resources | NYSE: IDR | 2025 | $42.4m | $16.7m |
| IDEAYA Biosciences | NASDAQ: IDYA | 2025 | $218.7m | −$113.7m |
| IDEX | NYSE: IEX | 2025 | $3,458m | $483.2m |
| IDEXX Laboratories | NASDAQ: IDXX | 2025 | $4,304m | $1,059m |
| IDT | NYSE: IDT | 2026 | $1,298m | $86.6m |
| IES | NASDAQ: IESC | 2025 | $3,371m | $306.0m |
| iHeartMedia | NASDAQ: IHRT | 2025 | $3,865m | −$472.9m |
| Illinois Tool Works | NYSE: ITW | 2025 | $16,044m | $3,066m |
| Illumina | NASDAQ: ILMN | 2025 | $4,343m | $850.0m |
| IMAX | NYSE: IMAX | 2025 | $410.2m | $34.9m |
| Immersion | NASDAQ: IMMR | 2026 | $1,731m | $4.5m |
| Immix Biopharma | NASDAQ: IMMX | 2025 | — | −$29.4m |
| Immuneering | NASDAQ: IMRX | 2025 | — | −$56.0m |
| Immunitybio | NASDAQ: IBRX | 2025 | $113.3m | −$351.4m |
| Immunocore | NASDAQ: IMCR | 2025 | $400.0m | −$35.5m |
| Immunome | NASDAQ: IMNM | 2025 | $6.9m | −$212.4m |
| Immunovant | NASDAQ: IMVT | 2026 | — | −$505.6m |
| Impinj | NASDAQ: PI | 2025 | $361.1m | −$10.8m |
| Incyte | NASDAQ: INCY | 2025 | $5,141m | $1,287m |
| Independence Realty Trust | NYSE: IRT | 2025 | $657.7m | $56.6m |
| Independent Bank | NASDAQ: IBCP | 2025 | $225.7m | $68.5m |
| Independent Bank (INDB) | NASDAQ: INDB | 2025 | $857.5m | $205.1m |
| Indie Semiconductor | NASDAQ: INDI | 2025 | $217.4m | −$143.1m |
| Indivior Pharmaceuticals | NASDAQ: INDV | 2025 | $1,239m | $210.0m |
| Industrial Logistics Properties Trust | NASDAQ: ILPT | 2025 | $448.8m | −$66.2m |
| Information Services Group | NASDAQ: III | 2025 | $244.7m | $9.3m |
| InfuSystem | NYSE: INFU | 2025 | $143.4m | $6.6m |
| Ingersoll Rand | NYSE: IR | 2025 | $7,651m | $581.4m |
| Ingevity | NYSE: NGVT | 2025 | $1,168m | −$167.1m |
| Ingles Markets | NASDAQ: IMKTA | 2025 | $5,334m | $83.6m |
| Ingram Micro | NYSE: INGM | 2025 | $52,556m | $327.9m |
| Ingredion | NYSE: INGR | 2025 | $7,219m | $729.0m |
| Inhibikase Therapeutics | NASDAQ: IKT | 2025 | — | −$48.3m |
| Inhibrx Biosciences | NASDAQ: INBX | 2025 | $1.3m | −$140.1m |
| Innodata | NASDAQ: INOD | 2025 | $251.7m | $32.2m |
| Innospec | NASDAQ: IOSP | 2025 | $1,778m | $116.6m |
| InnovAge | NASDAQ: INNV | 2026 | $989.7m | −$2.5m |
| Innovate | NYSE: VATE | 2025 | $1,246m | −$60.6m |
| Innovative Industrial Properties | NYSE: IIPR | 2025 | $266.0m | $118.2m |
| Innovex International | NYSE: INVX | 2025 | $978.3m | $83.3m |
| Innoviva | NASDAQ: INVA | 2025 | $411.3m | $271.2m |
| Inogen | NASDAQ: INGN | 2025 | $348.7m | −$22.7m |
| Inseego | NASDAQ: INSG | 2025 | $166.2m | $0.8m |
| Insight Enterprises | NASDAQ: NSIT | 2025 | $8,247m | $157.3m |
| Insmed | NASDAQ: INSM | 2025 | $606.4m | −$1,277m |
| Insperity | NYSE: NSP | 2025 | $6,812m | −$7.0m |
| Inspire Medical Systems | NYSE: INSP | 2025 | $912.0m | $145.4m |
| Inspired Entertainment | NASDAQ: INSE | 2025 | $304.1m | −$17.0m |
| Installed Building Products | NYSE: IBP | 2025 | $2,971m | $265.4m |
| Insteel Industries | NYSE: IIIN | 2026 | $739.5m | $29.5m |
| Insulet | NASDAQ: PODD | 2025 | $2,708m | $247.1m |
| Intapp | NASDAQ: INTA | 2026 | $577.8m | −$41.3m |
| Integer | NYSE: ITGR | 2025 | $1,854m | $102.8m |
| Integra Lifesciences | NASDAQ: IART | 2025 | $1,635m | −$516.5m |
| Intel | NASDAQ: INTC | 2025 | $52,853m | −$267.0m |
| Intellia Therapeutics | NASDAQ: NTLA | 2025 | $67.7m | −$412.7m |
| Intellicheck | NASDAQ: IDN | 2025 | $22.7m | $1.3m |
| Interactive Brokers | NASDAQ: IBKR | 2025 | $6,205m | $4,357m |
| Intercontinental Exchange | NYSE: ICE | 2025 | $12,640m | $3,315m |
| Intercorp Financial Services | NYSE: IFS | 2025 | — | PEN 1,932m |
| InterDigital | NASDAQ: IDCC | 2025 | $834.0m | $406.6m |
| Interface | NASDAQ: TILE | 2025 | $1,387m | $116.1m |
| International Bancshares | NYSE: IBOC | 2025 | $842.2m | $412.3m |
| International Flavors & Fragrances | NYSE: IFF | 2025 | $10,890m | −$359.0m |
| International Money Express | NASDAQ: IMXI | 2025 | $607.8m | $32.7m |
| International Paper | NYSE: IP | 2025 | $23,634m | −$3,516m |
| International Seaways | NYSE: INSW | 2025 | $843.3m | $309.3m |
| Interparfums | NASDAQ: IPAR | 2025 | $1,489m | $168.4m |
| Intest | NYSE: INTT | 2025 | $113.8m | −$2.5m |
| Intrepid Potash | NYSE: IPI | 2025 | $298.3m | $11.2m |
| Intuit | NASDAQ: INTU | 2026 | $21,448m | $4,566m |
| Intuitive Machines | NASDAQ: LUNR | 2025 | $210.1m | −$83.3m |
| Intuitive Surgical | NASDAQ: ISRG | 2025 | $10,065m | $2,856m |
| Inventrust Properties | NYSE: IVT | 2025 | $299.2m | $111.4m |
| Invesco | NYSE: IVZ | 2025 | $6,377m | −$174.8m |
| Invesco Mortgage Capital | NYSE: IVR | 2025 | $295.3m | $101.3m |
| Investar | NASDAQ: ISTR | 2025 | $93.6m | $22.9m |
| Investors Title | NASDAQ: ITIC | 2025 | $272.8m | $35.2m |
| Invitation Homes | NYSE: INVH | 2025 | $2,729m | $587.9m |
| Invivyd | NASDAQ: IVVD | 2025 | $53.4m | −$52.5m |
| Ionis Pharmaceuticals | NASDAQ: IONS | 2025 | $943.7m | −$381.4m |
| IonQ | NYSE: IONQ | 2025 | $130.0m | −$510.4m |
| Iovance Biotherapeutics | NASDAQ: IOVA | 2025 | $263.5m | −$391.0m |
| IPG Photonics | NASDAQ: IPGP | 2025 | $1,004m | $31.1m |
| IQVIA | NYSE: IQV | 2025 | $16,310m | $1,360m |
| Iradimed | NASDAQ: IRMD | 2025 | $83.8m | $22.5m |
| IREN | NASDAQ: IREN | 2026 | $707.0m | −$702.6m |
| iRhythm | NASDAQ: IRTC | 2025 | $747.1m | −$44.6m |
| Iridium Communications | NASDAQ: IRDM | 2025 | $871.7m | $114.4m |
| Iron Mountain | NYSE: IRM | 2025 | $6,902m | $152.3m |
| Ironwood Pharmaceuticals | NASDAQ: IRWD | 2025 | $296.2m | $24.0m |
| IRSA | NYSE: IRS | 2026 | — | ARS 393,510m |
| Isabella Bank | NASDAQ: ISBA | 2025 | $78.5m | $18.9m |
| Itaú Unibanco | NYSE: ITUB | 2025 | BRL 167,780m | BRL 44,857m |
| Itron | NASDAQ: ITRI | 2025 | $2,367m | $301.1m |
| ITT | NYSE: ITT | 2025 | $3,939m | $488.0m |
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell.